Blog
RSS FeedPosted by Michael Wonder on 12 Jan 2021
Decision to widen access to valganciclovir for transplant patients
12 January 2021 - PHARMAC is pleased to announce a decision to widen access to valganciclovir for use after lung ...
Posted by Michael Wonder on 10 Jan 2021
Crohn's disease and colitis sufferers plead with PHARMAC to fund new drug
5 January 2021 - Sufferers of Crohn's disease and colitis are pleading with PHARMAC to fund a drug that's available ...
Posted by Michael Wonder on 01 Jan 2021
New Zealand Pharmaceutical Schedule - 1 January 2021
1 January 2021 - The January 2021 issue of the New Zealand Pharmaceutical Schedule is now available and in effect. ...
Posted by Michael Wonder on 21 Dec 2020
Kiwis going into debt to pay for drugs other countries fund
21 December 2020 - An internal stoush at the drug-buying agency PHARMAC has blocked funding for a life-extending drug for bowel ...
Posted by Michael Wonder on 21 Dec 2020
PHARMAC to fund new diabetes medicines with amended Special Authority criteria
21 December 2020 - PHARMAC has approved funding for two new medicines with substantial health benefits for around 53,000 New Zealanders ...
Posted by Michael Wonder on 16 Dec 2020
Year in review
16 December 2020 - PHARMAC claims it funded 14 new medicines, including six new cancer medicines, and widened access to ...
Posted by Michael Wonder on 14 Dec 2020
Diabetes drugs delay shows problem with PHARMAC’s funding model, doctor claims
14 December 2020 - Pharmac’s decision to delay funding approval for two new diabetes drugs has highlighted the shortcomings of ...
Posted by Michael Wonder on 10 Dec 2020
Proposal to widen access to febuxostat for prevention of tumour lysis syndrome
10 December 2020 - PHARMAC is seeking feedback on a proposal to widen access to febuxostat tablets. ...
Posted by Michael Wonder on 09 Dec 2020
'We're feeling broken': Taranaki father of six dies after battle for cancer drug funding
10 December 2020 - A Taranaki father who fought to get vital cancer drugs funded by the Government has lost his ...
Posted by Michael Wonder on 07 Dec 2020
PHARMAC diabetes drugs delay 'bewildering', 'worse than disappointing' - doctors
7 December 2020 - A decision by PHARMAC to defer the approval of two new drugs for the treatment of diabetes ...
Posted by Michael Wonder on 07 Dec 2020
Jacinda Ardern defends Labour's 'perfectly reasonable' decision to veto MP led PHARMAC inquiry
7 December 2020 - Prime Minister Jacinda Ardern is defending Labour's "perfectly reasonable" decision to veto a PHARMAC inquiry led ...
Posted by Michael Wonder on 07 Dec 2020
Update on funding decision for two new diabetes medicines
7 December 2020 - PHARMAC would like to thank everyone who has provided feedback to date on a proposal to ...
Posted by Michael Wonder on 04 Dec 2020
PHARMAC inquiry: “nothing should be off the table”
4 December 2020 - Medicines New Zealand, the industry association representing companies involved in the research, development and manufacture of ...
Posted by Michael Wonder on 04 Dec 2020
Proposal to widen access to rituximab for treatment of membranous nephropathy
4 December 2020 - PHARMAC is seeking feedback on a proposal to widen access to rituximab. ...
Posted by Michael Wonder on 03 Dec 2020
Fate of 250,000 diabetics in PHARMAC’s hands
3 December 2020 - This week, a small group of bureaucrats and health professionals will meet to agree on the ...